MedTrace Logo

Regional Midazolam in Quadratus Lumborum Block

NCT05261672 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-11-18

No results posted yet for this study

Summary

Midazolam has been used in regional anesthesia of brachial plexus block; it has offered accepted postoperative pain relief. This study will use it in as an adjuvant to bupivacaine 0.25% in quadratus lumborum block in caesarean section

Conditions

  • Postoperative Pain

Interventions

DRUG

Midazolam/ bupivaciane

20 ml bupivacaine 0.25% will be injected + 2 mg midazolam in 1 ml saline on each side.

DRUG

Bupivacain

20 ml bupivacaine 0.25% will be injected + 1 ml saline on each side

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
24 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2023-12-31
Completion
2024-01-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05261672 on ClinicalTrials.gov